Filing Flows › Cumberland Pharmaceuticals (CPIX) › R&D spending
Cumberland Pharmaceuticals (CPIX) R&D spending by quarter
Cumberland Pharmaceuticals' R&D spending was $772K in Q2 2026 (second quarter 2026), -47% from Q1 2026. Over the last 7 quarters it ranged from $772K (Q2 2026) to $1.5M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $772K | -47% | -47% |
| Q1 2026 | $1.5M | -6% | +13% |
| Q4 2025 | $1.5M | +24% | +20% |
| Q3 2025 | $1.3M | -15% | — |
| Q2 2025 | $1.5M | +13% | — |
| Q1 2025 | $1.3M | +0.2% | — |
| Q4 2024 | $1.3M | — | — |
Q2 2026 at a glance
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
Questions
What is Cumberland Pharmaceuticals' R&D spending?
Cumberland Pharmaceuticals' R&D spending was $772K in Q2 2026 (second quarter 2026), -47% from Q1 2026.
How has Cumberland Pharmaceuticals' R&D spending changed?
Over the last 7 quarters it ranged from $772K (Q2 2026) to $1.5M (Q4 2025).
Q2 2026 results → · How Cumberland Pharmaceuticals makes money →